8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms

8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms

Acid-base homeostasis maintains arterial blood pH within a narrow physiological range of $7.35–7.45$ ($[\text{H}^+] \approx 35–45\text{ nmol/L}$). Precise pH control is required to prevent protein denaturation and preserve enzyme kinetics. Acid-base stability relies on instantaneous chemical buffering, rapid respiratory response, and definitive renal excretion of non-volatile acids.

---

Henderson-Hasselbalch Kinetics and Reference Values

The primary extracellular buffer is the bicarbonate-carbonic acid buffer system:

$$\text{CO}_2 + \text{H}_2\text{O} \xleftrightarrow{\text{Carbonic Anhydrase}} \text{H}_2\text{CO}_3 \xleftrightarrow{} \text{H}^+ + \text{HCO}_3^-$$

The Henderson-Hasselbalch Equation

Systemic pH is mathematically defined by the Henderson-Hasselbalch equation:

$$\text{pH} = \text{pK}_a + \log \left( \frac{[\text{HCO}_3^-]}{[\text{H}_2\text{CO}_3]} \right) = 6.1 + \log \left( \frac{[\text{HCO}_3^-]}{0.03 \cdot P_{\text{CO}_2}} \right)$$

Where $0.03$ is the solubility coefficient of $\text{CO}_2$ in blood ($\text{mmol/L per mmHg}$), $P_{\text{CO}_2}$ reflects respiratory control, and $[\text{HCO}_3^-]$ reflects renal metabolic control.

Normal Arterial Blood Gas (ABG) Reference Ranges

• pH: $7.35 – 7.45$ (Acidemia $< 7.35$; Alkalemia $> 7.45$)
• $P_{\text{CO}_2}$: $35 – 45\text{ mmHg}$ (Primary respiratory component)
• $[\text{HCO}_3^-]$: $22 – 26\text{ mEq/L}$ (Primary metabolic component)

---

Primary Acid-Base Disturbances and Compensatory Rules

When a primary disturbance alters pH, the opposing system initiates compensatory responses to return the $[\text{HCO}_3^-] / P_{\text{CO}_2}$ ratio toward normal. Compensation never fully overcorrects arterial pH back to $7.40$.

---

Metabolic Acidosis and Serum Anion Gap

Metabolic acidosis originates from primary reduction in $[\text{HCO}_3^-] < 22\text{ mEq/L}$. Diagnostic evaluation begins by calculating the Serum Anion Gap (AG):

$$\text{Anion Gap (AG)} = [\text{Na}^+] - \left( [\text{Cl}^-] + [\text{HCO}_3^-] \right) \quad (\text{Normal: } 8\text{--}12\text{ mEq/L})$$

Albumin Correction: Corrected $\text{AG} = \text{AG} + 2.5 \cdot (4.0 - \text{Patient Albumin in g/dL})$.

Metabolic Acidosis (pH < 7.35, HCO3- < 22)
 ├── High Anion Gap (> 12 mEq/L): MUDPILES / GOLDMARK (Organic Acid Accumulation)
 └── Normal Anion Gap (8-12 mEq/L): Hyperchloremic (Diarrhea, RTA Types 1, 2, 4)

1. High Anion Gap Metabolic Acidosis (HAGMA)

Caused by accumulation of unmeasured organic anions that consume $[\text{HCO}_3^-]$ without increasing $[\text{Cl}^-]$.

• MUDPILES Mnemonic:
  • Methanol (Formic acid)
  • Uremia (Advanced renal failure)
  • DKA (Diabetic Ketoacidosis: $\beta$-hydroxybutyrate)
  • Propylene glycol
  • Isoniazid / Iron
  • Lactic acidosis (L-lactate from tissue hypoperfusion)
  • Ethylene glycol (Oxalic and glycolic acid)
  • Salicylates (Aspirin toxicity—produces mixed HAGMA and primary respiratory alkalosis)
• GOLDMARK Mnemonic: Glycols, Oxoproline (acetaminophen overuse), L-lactate, D-lactate, Methanol, Aspirin, Renal failure, Ketoacidosis.

2. Normal Anion Gap Metabolic Acidosis (NAGMA / Hyperchloremic Acidosis)

Caused by direct loss of $\text{HCO}_3^-$ replaced reciprocally by $\text{Cl}^-$, preserving normal AG ($8–12\text{ mEq/L}$).

• Gastrointestinal Losses: Severe diarrhea, pancreatic fistula, ureterosigmoidostomy.
• Renal Tubular Acidosis (RTA):
  • Type 1 (Distal RTA): Failure of $\alpha$-intercalated cells to secrete $\text{H}^+$. Impaired urine acidification (urine pH $> 5.5$). Causes hypokalemia, nephrolithiasis (calcium phosphate stones).
  • Type 2 (Proximal RTA): Defective PCT $\text{HCO}_3^-$ reabsorption. Urine pH initial $> 5.5$, later $< 5.5$ as filtered load drops. Associated with hypokalemia and Fanconi syndrome.
  • Type 4 (Hyperkalemic RTA): Aldosterone deficiency or resistance. Decreased distal $\text{Na}^+$ reabsorption impairs $\text{H}^+$ and $\text{K}^+$ secretion. Causes hyperkalemia and urine pH $< 5.5$.

---

Metabolic Alkalosis and Urinary Chloride Differentiation

Metabolic alkalosis ($[\text{HCO}_3^-] > 26\text{ mEq/L}$, $\text{pH} > 7.45$) is categorized by Urinary Chloride ($U_{\text{Cl}}$) responsiveness:

1. Saline-Responsive ($U_{\text{Cl}} < 20\text{ mEq/L}$)

• Mechanism: Volume depletion leads to ECF contraction, activating RAAS. Secondary hyperaldosterone increases distal $\text{H}^+$ secretion, while low luminal $\text{Cl}^-$ impairs Pendrin $\text{HCO}_3^-$ secretion. Responds to $0.9\%$ NaCl infusion.
• Causes: Vomiting, nasogastric suction, loop or thiazide diuretic therapy (post-dosing phase), contraction alkalosis.

2. Saline-Resistant ($U_{\text{Cl}} > 20\text{ mEq/L}$)

• Mechanism: Mineralocorticoid excess or profound hypokalemia directly drives distal $\text{H}^+$ secretion independent of volume. Unresponsive to saline resuscitation.
• Causes: Primary Hyperaldosteronism (Conn syndrome), Cushing syndrome, Bartter / Gitelman syndromes, severe hypokalemia ($[\text{K}^+] < 2.0\text{ mEq/L}$).

---

Respiratory Acid-Base Disorders

Respiratory Acidosis ($P_{\text{CO}_2} > 45\text{ mmHg}$, $\text{pH} < 7.35$)

• Etiologies: Hypoventilation from opioid overdose, COPD, acute severe asthma, neuromuscular paralysis (Guillain-Barré, ALS).
• Biphasic Compensation: Acute compensation relies on intracellular protein buffering ($+1\text{ mEq/L } \text{HCO}_3^-$ per $10\text{ mmHg} \uparrow P_{\text{CO}_2}$). Chronic compensation (3–5 days) requires renal upregulation of $\text{H}^+$-ATPase and ammoniagenesis ($+3.5–4\text{ mEq/L } \text{HCO}_3^-$ per $10\text{ mmHg} \uparrow P_{\text{CO}_2}$).

Respiratory Alkalosis ($P_{\text{CO}_2} < 35\text{ mmHg}$, $\text{pH} > 7.45$)

• Etiologies: Hyperventilation from panic attacks, high-altitude hypoxia, pulmonary embolism, early salicylate toxicity, mechanical ventilation.
• Biphasic Compensation: Acute compensation shifts $\text{H}^+$ out of cells ($-2\text{ mEq/L } \text{HCO}_3^-$ per $10\text{ mmHg} \downarrow P_{\text{CO}_2}$). Chronic compensation (3–5 days) involves renal reduction in $\text{H}^+$ secretion and $\beta$-intercalated $\text{HCO}_3^-$ excretion ($-5\text{ mEq/L } \text{HCO}_3^-$ per $10\text{ mmHg} \downarrow P_{\text{CO}_2}$).